Aledade Stock

aledade.comHealthcare / Healthcare providers & servicesFounded: 2014Funding to Date: $696.82MM

Aledade is a healthcare company that partners with independent, primary care physicians to provide everything the doctors need to create and run an Accountable Care Organization (ACO) – from business and practice transformation services to upfront capital and a cutting-edge technology platform.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Aledade, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Aledade’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Aledade.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Mandy Cohen
Executive Vice President & Chief Executive Officer, Aledade Care Solutions
Farzad Mostashari MD
Co-Founder & Chief Executive Officer
Mat Kendall
Co-Founder & President
Douglas Street
Chief Operating Officer of Aledade Care Solutions & Chief of Staff
Ritwik Tewari
Chief Technology Officer
Phuong Phillips
Chief Legal Officer
Ahmed Haque
Chief Performance Officer
Nick Kinkaid
Chief Product Officer
Ananya Banerjee
Chief Commercial Officer
Emily Maxson MD
Chief Medical Officer
John Doyle
Chief Financial Officer
Dan Bowles
Chief Growth Officer
Sean Cavanaugh
Chief Policy Officer

Board Members

Julie Sunderland
Biomatics Capital
Robert Kocher MD
Venrock

Aledade stock FAQs

plusminus

Can you buy Aledade stock?

As Aledade is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Aledade, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Aledade stock?

To invest in a private company like Aledade through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Aledade stock?

Yes, you may be able to sell your Aledade stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Aledade stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Aledade stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Aledade a public company?

No, Aledade is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Aledade’s stock price?

Aledade is a privately held company and therefore does not have a public stock price. However, you may access Aledade’s private market stock price with Forge Data.
plusminus

What is Aledade’s stock ticker symbol?

Aledade does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
When we first met Aledade, co-founder and CEO Dr. Farzad Mostashari invited us to learn about the company, but also left us with a polite, albeit straightforward warning: this is a complex business, and we’d have to put in the work to understand the opportunity. We’re glad we accepted the challenge, and we are excited to lead Aledade’s $260M Series F financing round.
Aledade, a company that helps US doctors adapt their practices to new payment arrangements aimed at improving care and cutting costs, raised $260 million in venture capital to expand its network. The deal values the company at $3.5 billion, according to people familiar with the situation, with investors buying in on similar terms to the company’s most recent funding round last year.
Aledade, the nation’s largest network of independent primary care, and Humana Inc. (NYSE: HUM), leading health insurer and health care services company, have announced a 10-year collaboration to provide value-based primary care for Humana’s Medicare Advantage members from in-network Aledade-enabled physicians.
Aledade, a Bethesda, Md.-based company enabling doctors to control health care, closed a $100m Series D funding round
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.